We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
Advice for healthcare professionals on the reclassification of codeine linctus to a prescription-only medicine (POM), following a public consultation.
This is an evidence based toolkit to support dental teams in improving their patient’s oral and general health.
Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.
Legal terms for veterinary medicines, marketing of non-medicinal products including medicinal words and phrases, how to complain.
The MHRA has reviewed the latest evidence relating to the very rare risk of PRES and RCVS associated with medicines containing pseudoephedrine
Guidance for living safely with respiratory infections, including coronavirus (COVID-19).
Guidance for people with symptoms of a respiratory infection including COVID-19, or a positive test result for COVID-19.
OPSS is leading a fresh campaign to raise awareness among parents and carers about potential hazards to children associated with swallowing small magnets, button batteries, loose/small toy parts and imitation food.
Directory of current ICH Guidelines which have been implemented by the Medicines and Healthcare products Regulatory Agency.
Risk minimisation materials are available to support the safe use of new paediatric formulations of rivaroxaban (Xarelto) and dabigatran etexilate (Pradaxa). In addition, we ask healthcare professionals to consult the current advice to ensure that all patients with renal impairment...
Information for pertussis (whooping cough) oral fluid testing.
Information on how to gain a UK CoC for working Deck and Engineering Officers working on board merchant vessels and yachts.
How investigators and sponsors should manage clinical trials during COVID-19
How to submit your periodic safety update report report (PSUR) or periodic benefit risk evaluation report (PBRER)
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.